KIT and glioblastoma: Interestingly, we found that SDH-deficient GISTs showed TIS scores closer to glioblastoma multiforme and kidney renal papillary cell carcinoma, while KIT-mutant GISTs placed near to breast cancer and pancreatic adenocarcinoma.